Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilocarpine and Brimonidine for Near Visual Acuity in Pseudophakia
NCT03825081Phase 1Unknown
- Sponsor
- Massachusetts Eye and Ear
- Start
- Jan 2019
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pilocarpine and brimonidine in presbyopia, sponsored by Massachusetts Eye and Ear. Primary endpoint: Change in visual acuity after administration of pilocarpine and brimonidine at 1 hour. Status: unknown.
02
Drugs
pilocarpinebrimonidine
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT03825081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03825081.